PharmaBoardroom

Regulatory, Pricing and Reimbursement Overview: Algeria

An insight into regulatory, pricing and reimbursement in Algeria. Prepared in association with SAARPE Association, a leading law firm in Algeria, this…

Antal Feller – CEO, Hungaropharma, Hungary

Dr Antal Feller, CEO of Hungaropharma, gives his insights on the pharma trends affecting the wholesale supply chain and product delivery in Hungary,…

Francesco Banchi – General Manager, Boehringer Ingelheim…

Francesco Banchi, general manager of Boehringer Ingelheim Hungary, elaborates on the successful development of the affiliate in recent years, making…

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving…

UAE to Boost Health Research Capabilities as Part of 50-Year…

The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of decisions and legislation to support…

Mandatory Vaccination in Romania: Back to Vax

As anti-vaccination sentiments resurface globally, so have once-eradicated diseases. This situation is especially prevalent in Romania and has become…

Mexico: Despite Hurdles, Pharma Market Remains Attractive

The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP…

The Fight Against Superbugs: Properly Incentivising Antimicrobial…

BIO's Greg Frank outlines the alarming growth of drug-resistant infections and the steps that need to be taken to combat this rapidly emerging global…